Medical and surgical management of functional ovarian cysts;Traitement médical et chirurgical des kystes de l'ovaire fonctionnels

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 30, Issue SPEC. ISS. 1, 2001, Pages

  Brun, J L ^a   Le Touze O ^a   Leng, J J ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Medical treatment; Ovarian functional cysts; Surgical treatment

Indexed keywords

CA 125 ANTIGEN; DANAZOL; GESTAGEN; GONADORELIN; HEMOSIDERIN; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN;

BENIGN TUMOR; CANCER PATIENT; COLOR ULTRASOUND FLOWMETRY; DISEASE MARKER; DRUG FORMULATION; DRUG MEGADOSE; DRUG SAFETY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OVARY CYST; OVARY HYPERSTIMULATION; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; REVIEW; TREATMENT INDICATION; ULTRASOUND;

EID: 0035211316     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Ovarian neoplasms functional ovarian cysts oral contraceptives
2. Preoperative hormonal therapy of cystic adnexial masses
3. Que deviennent les kystes para-utérins ponctionnés sous cœlioscopie? Apport de 1'échographie
4. Chirurgie per-cœlioscopique des kystes ovariens: Indications et limites à propos d'une série de 169 kystes
5. Laparoscopic management of adnexial cystic masses
6. Place actuelle de la cœlioscopie dans le diagnostic et le traitement des kystes ovariens
7. Exérèse cœliochirurgicale de kystes annexiels: Méthodes et indications sur une série de 70 patientes
8. Kystes de l'ovaire: Stratégie et pronostic
9. Kystes ovariens: Aspects diagnostiques et thérapeutiques
10. Kystes ovariens bénins en périménopause
11. Étude biologique du contenu des kystes de l'ovaire. Place dans la prise en charge des formations pelviennes liquidiennes
12. Traitement des kystes de l'ovaire par cœlioscopie
13. Regression of functional cysts: High dosage ovulation inhibit and gestagen therapy has no added effect
14. Expectant management of functional ovarian cysts: An alternative to hormonal therapy
15. Is hormonal treatment efficacious in the management of ovarian cysts in women with histories of endometriosis
16. Aspiration and tetracycline sclerotherapy for management of simple ovarian cysts
17. Ultrasound guided aspiration of benign ovarian cysts: An alternative to surgery?
18. The « simple » ovarian cyst: Aspirate or operate?
19. Role of puncture and aspiration in expectant managment of simple ovarian cysts: A randomised study
20. Evaluation of ovarian findings in asymptomatic postmenopausal women with color doppler ultrasound
21. Conduite à tenir devant une image liquidienne pelvienne uniloculaire découverte chez une femme ménopausée
22. Adnexial masses in postmenopausal women
23. Ovarian masses in postmenopausal women
24. Cystic lesions in elderly women, diagnosed by ultrasound
25. The postmenopausal adnexial mass. Correlation between ultrasonic and pathologic findings
26. Transvaginal ultrasonographic characterization of ovarian masses by means of color flow-directed Doppler measurements and a morphologic scoring system
27. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: Criteria to be used for ultrasound evaluation
28. Diagnosis and follow-up of simple ovarian cysts detected by ultrasound in postmenopausal women
29. Follow-up of small, postmenopausal ovarian cysts using vaginal ultrasound and CA-125 antigen
30. Relation entre la tuberculose génitale et les kystes simples de l'ovaire
31. The pathology of female genital tuberculosis
32. Cystic ovarian enlargement resulting from autoimmune oophoritis
33. A case-control study of benign ovarian tumours
34. Ovarian cysts in women with inflammatory bowel disease
35. Functional ovarian cysts and oral contraceptives: Negative association confirmed surgically
36. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives
37. Oral contraceptives type and functional ovarian cysts
38. A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development
39. Ovulation and follicular development associated with three low-dose oral contraceptives
40. Ovarian function during low-dose oral contraceptive use
41. Combinaison oral contraceptive pills: How do they differ?
42. Oral contraceptive use and benign gynecologic conditions: A review
43. Ovarian cysts and hormonal contraception
44. Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception
45. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties
46. The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women
47. Ovarian cysts decrease the success of controlled ovarian stimulation and in vitro fertilization
48. The effects of baseline ovarian cysts on cycle fecundity in controlled ovarian hyperstimulation
49. Baseline ovarian cysts do not affect clinical response to controlled ovarian hyperstimulation for in-vitro fertilization
50. Non-functional ovarian cysts do not affect ipsilateral or contralateral ovarian performance during in-vitro fertilization
51. Effect of baseline ovarian cysts on in-vitro fertilization and gamete intrafallopian transfer cycles
52. Ultrasonic assessment of subsequent unexplained infertility after ovulation induction
53. Persistent ovarian cysts following administration of human menopausal and chorionic gonadotropins: An attenuated form of ovarian hyperstimulation syndrome
54. Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins
55. Kystes ovariens fonctionnels: Existe-t-il un traitement médical?
56. Hormonal treatment of functional ovarian cysts: A randomized, prospective study
57. Management of functional ovarian cysts after induction of ovulation
58. Clinical management of functional ovarian cysts: A prospective and randomized study
59. Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen
60. Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer
61. Ovarian cysts in women receiving tamoxifen for breast cancer
62. Ovarian cysts in tamoxifen-treated premenopausal women with breast cancer - A management dilemna
63. Ovarían cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer
64. Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer
65. Successful co-treatment with LHRH-agonist for ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure
66. Ovarian size in postmenopausal women
67. Tumeurs et kystes ovariens après 50 ans: Étude rétrospective des années 1979 à 1989 au C.M.C Foch
68. Prevalence of simple adnexal cysts in postmenopausal women
69. Simple adnexal cysts: The natural history in postmenopausal women
70. Place des lésions inflammatoires péritonéales dans l'étiologie de certaines dystrophies ovariennes secondaires
71. Adhesions and pelvic pain: A retrospective study
72. Syndromes adhérentiels pelviens douloureux
73. Peritoneal inclusion cysts and their relationship to the ovaries: Evaluation with sonography
74. Peritoneal inclusion cysts: Ovarian fluid in peritoneal adhesions
75. Surgical transposition of the ovaries: Imaging findings in 14 patients
76. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination
77. Subcutaneous transposition of the ovary following hysterectomy
78. Successful treatment of a persistent cyst, developing after ovarian transposition with leuprolide acetate